vaccine - search results

Angela Morris, CEO, The Wool Packaging Company Ltd talks about challenging pharmaceutical cold chain packaging convention.

The Institute of Hygiene, Westfälische Wilhelms-Universität Münster highlights the changes in microbal pathogenicity

By providing the infrastructure to support drug discovery, the IMI is accelerating access to innovative medicines, as the EFPIA highlights here Innovation is the lifeblood of the pharmaceutical industry, providing us with the potential to cross new therapeutic frontiers to bring novel medicines to market that benefit patients and deliver...

Ingenuity Lab discuss the development of over the horizon solutions to global challenges. Our modern world seems to get more complex every day. As our technological sophistication increases, it appears that the challenges facing humanity have also grown. As a society we are focused on solving the grand problems of our...

Eradicating malaria will not be easy or cheap, but it will be worthwhile in the long run, argues Professor David H Peyton of Portland State University Malaria is several things: A group of related parasites, an infectious disease that is transmitted by mosquitoes (if you are a human) or by...

Artur Summerfield, the University of Bern discusses translating basic immunology to innovative and sustainable solutions for animal health and welfare.

Spaceflight Bill aims to send scientists into space for zero-gravity experiments and start commercial flights from the first UK spaceport within three years New powers announced today will pave the way for satellite launches, horizontal flights to the edge of space for scientific experiments, and the building of spaceports in...

Open Access Government considers progress in malaria research, aiming to eradicate the disease, by the US National Institute of Allergy and Infectious Diseases The National Institute of Allergy and Infectious Diseases (NIAID) has a longstanding commitment to malaria research and is the lead agency in the US federal government supporting...

Health First Europe’s honorary president, John Bowis, looks forward to a new EU action plan on antimicrobial resistance and healthcare-associated infections “Excessive and inappropriate use of antibiotics and poor infection control practices have progressively turned AMR into a massive threat for humankind. With rising resistance and no action, we would...

Marco Ferrazzoli, Head of the Press Office of Italian National Research Council, and professor at University of Rome Tor Vergata, highlights their aim to make science popular for young people in the country 'Quo Vado?' of Checco Zalone, the film that has broken all Italian records at the box office,...

A new team from the UK will provide rapid support for public health issues around the world, helping to control global disease outbreaks within 48 hours. The UK Public Health Rapid Support Team, set up by the Department of Health, the Department for International Development and Public Health England, is...

Ivo Holanec, Research Project Manager at the Institute and Faculty of Actuaries highlights a new report published regarding the significant problem of resistance to antimicrobials. This report examines the clinical implications, plausible effects on mortality and potential economic cost of antibiotic resistance… Antibiotics have been central to modern healthcare since...

European Parliament MEP Annie -Schreijer-Pierik (NL, EPP Group) and co-author of the resolution on Zika Virus, sheds light on what more could be done in Europe to help prevent the deadly disease… Europe should step up efforts to fight the Zika virus. More research, more money more awareness is needed....

Richard Bergström, Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA), highlights the importance of collaborative efforts to tackle antimicrobial resistance. Antimicrobial resistance (AMR) represents one of the most significant threats to global public health and also one against which the pharmaceutical industry is committed to fighting....

Welcome to the first edition of 2016. As we head into a New Year, growth and jobs remain the key priority for the European Commission – despite the European Union managing a number of crises, such as climate change. In the President’s New Year Conference, President Jean-Claude Juncker underlined his...

Although a small field in medicine, dermatological diseases are very frequent and span a wide range of illnesses such as allergies, inflammation (e.g. atopic dermatitis, psoriasis), autoimmune diseases or malignancies (e.g. melanoma). Thus, translational dermatological research is an important, innovative field for future basic and clinical research for many...

Infectious diseases are a major cause for animal suffering and production losses in livestock and at the same time, often being zoonotic, represent a serious hazard for food safety. Combating infectious diseases of livestock is, therefore, a top priority on the veterinary and public health agenda. Mass use of...

Ramón Cacabelos, of EuroEspes Biomedical Research Center discusses the strides being made in drug development for Alzheimer's disease... Alzheimer’s disease (AD) is a major problem of health and a national priority in developed countries. Despite enormous efforts by governments, the scientific community and the pharmaceutical industry over the past 50 years,...

Difficulties manufacturing vaccines could leave the UK vulnerable to future epidemic… A new report from MPs on the Science and Technology Committee has warned the UK “lacks the capacity” to create enough vaccines to protect people. Concerns were raised by the committee, who said the government’s response to the Ebola epidemic...

Murat Gultekin, Vice-President of the European Society of Gynaecological Oncology (ESGO) highlights the importance of early detection of gynaecological cancers for prevention…  According to World Cancer Report 2014 (IARC), at least one third of cancers are preventable. This is true for gynaecological cancers, especially cervical cancer. However, less than 5%...